Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway (Clinical Epigenetics, (2018), 10, 1, (64), 10.1186/s13148-018-0495-y)

Wan Li; Jie Yi; Xiangjin Zheng; Shiwei Liu; Weiqi Fu; Liwen Ren; Li Li; Dave S.B. Hoon; Jinhua Wang; Guanhua Du

doi:10.1186/s13148-022-01317-4

Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway (Clinical Epigenetics, (2018), 10, 1, (64), 10.1186/s13148-018-0495-y)

Wan Li, Jie Yi, Xiangjin Zheng, Shiwei Liu, Weiqi Fu, Liwen Ren, Li Li, Dave S.B. Hoon, Jinhua Wang, Guanhua Du

Research output: Contribution to journal › Comment/debate

Abstract

Following publication of the original article [1], the authors noticed the errors in Fig. 4b and Fig. S4A in the supplementary material. The revised Fig. 4 has been presented with this erratum and the revised supplementary material with the inclusion of new Fig. S4A has been uploaded.

Original language	English
Article number	97
Journal	Clinical Epigenetics
Volume	14
Issue number	1
DOIs	https://doi.org/10.1186/s13148-022-01317-4
State	Published - Dec 2022

Access to Document

10.1186/s13148-022-01317-4

Cite this

@article{344b2c2f8eb2408bb9235e82a91abc7a,

title = "Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway (Clinical Epigenetics, (2018), 10, 1, (64), 10.1186/s13148-018-0495-y)",

abstract = "Following publication of the original article [1], the authors noticed the errors in Fig. 4b and Fig. S4A in the supplementary material. The revised Fig. 4 has been presented with this erratum and the revised supplementary material with the inclusion of new Fig. S4A has been uploaded.",

author = "Wan Li and Jie Yi and Xiangjin Zheng and Shiwei Liu and Weiqi Fu and Liwen Ren and Li Li and Hoon, {Dave S.B.} and Jinhua Wang and Guanhua Du",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2022.",

year = "2022",

month = dec,

doi = "10.1186/s13148-022-01317-4",

language = "English",

volume = "14",

journal = "Clinical Epigenetics",

issn = "1868-7075",

publisher = "BioMed Central Ltd.",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway (Clinical Epigenetics, (2018), 10, 1, (64), 10.1186/s13148-018-0495-y)

AU - Li, Wan

AU - Yi, Jie

AU - Zheng, Xiangjin

AU - Liu, Shiwei

AU - Fu, Weiqi

AU - Ren, Liwen

AU - Li, Li

AU - Hoon, Dave S.B.

AU - Wang, Jinhua

AU - Du, Guanhua

PY - 2022/12

Y1 - 2022/12

N2 - Following publication of the original article [1], the authors noticed the errors in Fig. 4b and Fig. S4A in the supplementary material. The revised Fig. 4 has been presented with this erratum and the revised supplementary material with the inclusion of new Fig. S4A has been uploaded.

AB - Following publication of the original article [1], the authors noticed the errors in Fig. 4b and Fig. S4A in the supplementary material. The revised Fig. 4 has been presented with this erratum and the revised supplementary material with the inclusion of new Fig. S4A has been uploaded.

UR - http://www.scopus.com/inward/record.url?scp=85135170447&partnerID=8YFLogxK

U2 - 10.1186/s13148-022-01317-4

DO - 10.1186/s13148-022-01317-4

M3 - Comment/debate

C2 - 35906708

AN - SCOPUS:85135170447

SN - 1868-7075

VL - 14

JO - Clinical Epigenetics

JF - Clinical Epigenetics

IS - 1

M1 - 97

ER -

Correction: miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway (Clinical Epigenetics, (2018), 10, 1, (64), 10.1186/s13148-018-0495-y)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this